Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032029
Filing Date
2022-11-14
Accepted
2022-11-14 16:08:08
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1004882
2 ex31-1.htm EX-31.1 17578
3 ex31-2.htm EX-31.2 17921
4 ex32-1.htm EX-32.1 6988
5 ex32-2.htm EX-32.2 7183
  Complete submission text file 0001493152-22-032029.txt   5106467

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lucd-20220930.xsd EX-101.SCH 40275
7 XBRL CALCULATION FILE lucd-20220930_cal.xml EX-101.CAL 54744
8 XBRL DEFINITION FILE lucd-20220930_def.xml EX-101.DEF 155639
9 XBRL LABEL FILE lucd-20220930_lab.xml EX-101.LAB 310879
10 XBRL PRESENTATION FILE lucd-20220930_pre.xml EX-101.PRE 255631
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 883694
Mailing Address ONE GRAND CENTRAL PLACE, SUITE 4600 NEW YORK NY 10165
Business Address ONE GRAND CENTRAL PLACE, SUITE 4600 NEW YORK NY 10165 212 949 4319
Lucid Diagnostics Inc. (Filer) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40901 | Film No.: 221385193
SIC: 3841 Surgical & Medical Instruments & Apparatus